Clinical Trial Update: Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4 [NA]

View source ↗

Summary

Phase 4 clinical trial evaluating neurofeedback-enhanced cognitive reappraisal training for anxiety-related disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Neurofeedback Enhanced Cognitive Reappraisal Training

Snippet

Sponsor: University of Michigan | Conditions: Anxiety, Social Anxiety Disorder | NA | Status: RECRUITING